KMT2A and acute myeloid leukemia: First, knocked down wild-type GNB2 in MLL-AML cell lines; NOMO1, MOLM13, and THP1, which showed high expression of wild-type GNB2 (Fig. 5c), resulted in significantly less proliferation compared to mock experiments (Fig. 8a–c).